deoxycytidine and Follicular Thyroid Carcinoma

deoxycytidine has been researched along with Follicular Thyroid Carcinoma in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (66.67)	24.3611
2020's	1 (33.33)	2.80

Authors

Authors	Studies
Gui, W; Han, Q; Li, W; Liu, C; Liu, H; Yang, X; Zhu, C	1
Bockisch, A; Dralle, H; Kegel, T; Mann, K; Matuszczyk, A; Petersenn, S; Schmoll, HJ; Voigt, W	1
De La Motte Rouge, T; Hassani, L; Khayat, D; Leenhardt, L; Menegaux, F; Mouawad, R; Spano, JP; Vano, Y; Vignot, S	1

Trials

2 trial(s) available for deoxycytidine and Follicular Thyroid Carcinoma

Article	Year
Chemotherapy with paclitaxel and gemcitabine in progressive medullary and thyroid carcinoma of the follicular epithelium. Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 2010, Volume: 42, Issue:1 Topics: Adenocarcinoma, Follicular; Adult; Aged; Carcinoma, Medullary; Deoxycytidine; Disease Progression; Drug Therapy, Combination; Female; Gemcitabine; Humans; Male; Middle Aged; Neoplasm Staging; Paclitaxel; Thyroid Neoplasms	2010
GEMOX regimen in the treatment of metastatic differentiated refractory thyroid carcinoma. Medical oncology (Northwood, London, England), 2012, Volume: 29, Issue:3 Topics: Adenocarcinoma, Follicular; Adenocarcinoma, Papillary; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Disease-Free Survival; Female; Humans; Male; Middle Aged; Off-Label Use; Organoplatinum Compounds; Salvage Therapy; Thyroid Neoplasms	2012

Article

Year

Chemotherapy with paclitaxel and gemcitabine in progressive medullary and thyroid carcinoma of the follicular epithelium.

Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 2010, Volume: 42, Issue:1

Topics: Adenocarcinoma, Follicular; Adult; Aged; Carcinoma, Medullary; Deoxycytidine; Disease Progression; Drug Therapy, Combination; Female; Gemcitabine; Humans; Male; Middle Aged; Neoplasm Staging; Paclitaxel; Thyroid Neoplasms

2010

GEMOX regimen in the treatment of metastatic differentiated refractory thyroid carcinoma.

Medical oncology (Northwood, London, England), 2012, Volume: 29, Issue:3

Topics: Adenocarcinoma, Follicular; Adenocarcinoma, Papillary; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Disease-Free Survival; Female; Humans; Male; Middle Aged; Off-Label Use; Organoplatinum Compounds; Salvage Therapy; Thyroid Neoplasms

2012

Other Studies

1 other study(ies) available for deoxycytidine and Follicular Thyroid Carcinoma

Article	Year
Precise engineering of Gemcitabine prodrug cocktails into single polymeric nanoparticles delivery for metastatic thyroid cancer cells. Drug delivery, 2020, Volume: 27, Issue:1 Topics: Adenocarcinoma, Follicular; Apoptosis; Cell Line, Tumor; Deoxycytidine; Drug Carriers; Gemcitabine; Humans; Linoleic Acid; Microscopy, Electron; Nanoconjugates; Nanoparticles; Polymers; Prodrugs; Thyroid Cancer, Papillary; Thyroid Neoplasms	2020

Article

Year

Precise engineering of Gemcitabine prodrug cocktails into single polymeric nanoparticles delivery for metastatic thyroid cancer cells.

Drug delivery, 2020, Volume: 27, Issue:1

Topics: Adenocarcinoma, Follicular; Apoptosis; Cell Line, Tumor; Deoxycytidine; Drug Carriers; Gemcitabine; Humans; Linoleic Acid; Microscopy, Electron; Nanoconjugates; Nanoparticles; Polymers; Prodrugs; Thyroid Cancer, Papillary; Thyroid Neoplasms

2020